SCHEMBL1413998

SCHEMBL1413998

O=C(O)c1cc(-c2ccccc2Cl)[nH]n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.59
▸ MEN1 O00255 7/20 0.59
▸ MAPT P10636 5/20 0.59
▸ HPGD P15428 3/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ ALOX15 P16050 3/20 0.59
▸ NFKB1 P19838 2/20 0.59
▸ NFKB2 Q00653 2/20 0.59
▸ RELA Q04206 2/20 0.59
▸ ALOX12 P18054 1/20 0.59
▸ HSD17B10 Q99714 1/20 0.59
▸ ALPL P05186 1/20 0.55
▸ NPC1 O15118 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ POLB P06746 1/20 0.51
▸ NPY5R Q15761 1/20 0.50
▸ HCAR2 Q8TDS4 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1222694 0.83 ALOX15 (0.61) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL25188817 0.83 ALPL (0.56) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL25183997 0.83 MEN1 (0.49) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL71193 0.81 MEN1 (0.51) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL3768295 0.81 ADORA3 (0.58) KMT2AMEN1MAPTALOX15HSD17B10
Hydrochloric Acid SCHEMBL11401357 0.79 ADORA3 (0.56) KMT2AMEN1MAPTALOX15HSD17B10
SCHEMBL69492 0.78 MEN1 (0.58) KMT2AMEN1MAPTSMN1; SMN2ALPL
SCHEMBL71938 0.77 HSD17B10 (0.60) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL29930951 0.77 HSD17B10 (0.60) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL70810 0.77 KMO (0.55) KMT2AMEN1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2291372-A2 INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF Burnham Institute for Medical Research (US) 2011-03-09 — — EP disclosed
US-20100016313-A1 INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-01-21 — — US disclosed
US-20100016313-A1 INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-01-21 — — US disclosed
US-20100016313-A1 INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-01-21 — — US disclosed
WO-2009143150-A2 INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-11-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016313-A1 INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF ALPI, SI, FABP2 KMT2A 3249/4885MEN1 4150/4885MAPT 4675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback